St. Louis, MO, United States of America

Chad Sylvester

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Nous Imaging, Inc., Turing Medical Technologies Inc.. Active years: 2023-2024.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Chad Sylvester in Neuromodulation

Introduction

Chad Sylvester is an accomplished inventor based in St. Louis, MO (US). He has made significant contributions to the field of neuromodulation, holding 2 patents that focus on personalized approaches to brain intervention. His work is characterized by a blend of advanced imaging techniques and functional mapping.

Latest Patents

Chad's latest patents include a groundbreaking method titled "Systems and method of precision functional mapping-guided interventional planning." This method provides a framework for performing personalized neuromodulation on subjects. It involves acquiring functional magnetic resonance imaging (fMRI) data of the brain, calculating functional connectivity between specific brain regions, and identifying target locations for neuromodulation based on this connectivity. This innovative approach aims to enhance the precision of brain interventions.

Career Highlights

Throughout his career, Chad has worked with notable companies such as Turing Medical Technologies Inc. and Nous Imaging, Inc. His experience in these organizations has allowed him to develop and refine his innovative techniques in neuromodulation.

Collaborations

Chad has collaborated with professionals like Scott Norris and Scott Marek, contributing to the advancement of his research and inventions.

Conclusion

Chad Sylvester's work in the field of neuromodulation exemplifies the intersection of technology and healthcare. His innovative patents and collaborations highlight his commitment to improving personalized medical interventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…